To Cite:
Farbood
Y, Mansouri
S M T, Ahmadian
S M, Mard
S A, Sarkaki
A. et al. Effect of Ellagic Acid on Animal Behavior in Elevated Plus Maze and Open Field Tests,
Jundishapur J Helath Res.
2015
;6(6):e29311.
doi: 10.17795/jjhr-29311.
1.
Pollack MH. New advances in the management of anxiety disorders. Psychopharmacol Bull. 2002; 36(4): 79-94[PubMed]
2.
Shorter E, Tyrer P. Separation of anxiety and depressive disorders: blind alley in psychopharmacology and classification of disease. BMJ. 2003; 327(7407): 158-60[DOI][PubMed]
3.
Kunovac JL, Stahl SM. Future directions in anxiolytic pharmacotherapy. Psychiatr Clin North Am. 1995; 18(4): 895-909[PubMed]
4.
Girish C, Raj V, Arya J, Balakrishnan S. Involvement of the GABAergic system in the anxiolytic-like effect of the flavonoid ellagic acid in mice. Eur J Pharmacol. 2013; 710(1-3): 49-58[DOI][PubMed]
5.
Medina JH, Peña C, Levi de Stein M, Wolfman C, Paladini AC. Benzodiazepine-like molecules, as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants. Biochem Biophys Res Commun. 1989; 165(2): 547-53[DOI]
6.
Priyadarsini KI, Khopde SM, Kumar SS, Mohan H. Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem. 2002; 50(7): 2200-6[PubMed]
7.
Kaur S, Grover IS, Kumar S. Antimutagenic potential of ellagic acid isolated from Terminalia arjuna. Indian J Exp Biol. 1997; 35(5): 478-82[PubMed]
8.
Makena PS, Chung KT. Effects of various plant polyphenols on bladder carcinogen benzidine-induced mutagenicity. Food Chem Toxicol. 2007; 45(10): 1899-909[DOI][PubMed]
9.
Cozzi R, Ricordy R, Bartolini F, Ramadori L, Perticone P, De Salvia R. Taurine and ellagic acid: two differently-acting natural antioxidants. Environ Mol Mutagen. 1995; 26(3): 248-54[PubMed]
10.
Rogerio AP,
Fontanari C,
Melo MC,
Ambrosio SR,
de Souza GE,
Pereira PS,
et al.
Anti-inflammatory, analgesic and anti-oedematous effects of Lafoensia pacari extract and ellagic acid. J Pharm Pharmacol. 2006; 58(9): 1265-73[DOI][PubMed]
11.
Papoutsi Z, Kassi E, Chinou I, Halabalaki M, Skaltsounis LA, Moutsatsou P. Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br J Nutr. 2008; 99(4): 715-22[DOI][PubMed]
12.
Kim S,
Gaber MW,
Zawaski JA,
Zhang F,
Richardson M,
Zhang XA,
et al.
The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. Biomaterials. 2009; 30(27): 4743-51[DOI]
13.
Yang CS, Tzou BC, Liu YP, Tsai MJ, Shyue SK, Tzeng SF. Inhibition of cadmium-induced oxidative injury in rat primary astrocytes by the addition of antioxidants and the reduction of intracellular calcium. J Cell Biochem. 2008; 103(3): 825-34[DOI]
14.
Bueno CH, Zangrossi Jr H, Viana MB. The inactivation of the basolateral nucleus of the rat amygdala has an anxiolytic effect in the elevated T-maze and light/dark transition tests. Brazil J Med Biol Res. 2005; 38(11): 1697-701[DOI]
15.
Carlo CN, Stefanacci L, Semendeferi K, Stevens CF. Comparative analyses of the neuron numbers and volumes of the amygdaloid complex in old and new world primates. J Comp Neurol. 2010; 518(8): 1176-98[DOI][PubMed]
16.
Pellow S, Chopin P, File SE, Briley M. Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985; 14(3): 149-67[DOI]
17.
Kõks S, Beljajev S, Koovit I, Abramov U, Bourin M, Vasar E. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze. Psychopharmacology. 2000; 153(3): 365-72[DOI]
18.
Archer J. Tests for emotionality in rats and mice: A review. Anim Behav. 1973; 21(2): 205-35[DOI]
19.
Galdino PM, Nascimento MV, Sampaio BL, Ferreira RN, Paula JR, Costa EA. Antidepressant-like effect of Lafoensia pacari A. St.-Hil. ethanolic extract and fractions in mice. J Ethnopharmacol. 2009; 124(3): 581-5[DOI][PubMed]
20.
Wang Q, Han Y, Xue H. Ligands of the GABAA Receptor Benzodiazepine Binding Site. CNS Drug Rev. 2006; 5(2): 125-44[DOI]
21.
Marder M, Paladini AC. GABA(A)-receptor ligands of flavonoid structure. Curr Top Med Chem. 2002; 2(8): 853-67[PubMed]
22.
Fernandez SP,
Wasowski C,
Loscalzo LM,
Granger RE,
Johnston GA,
Paladini AC,
et al.
Central nervous system depressant action of flavonoid glycosides. Eur J Pharmacol. 2006; 539(3): 168-76[DOI][PubMed]
23.
Hall BJ, Chebib M, Hanrahan JR, Johnston GA. 6-Methylflavanone, a more efficacious positive allosteric modulator of gamma-aminobutyric acid (GABA) action at human recombinant alpha2beta2gamma2L than at alpha1beta2gamma2L and alpha1beta2 GABA(A) receptors expressed in Xenopus oocytes. Eur J Pharmacol. 2005; 512(2-3): 97-104[DOI][PubMed]
24.
Girish C, Pradhan SC. Drug development for liver diseases: focus on picroliv, ellagic acid and curcumin. Fundam Clin Pharmacol. 2008; 22(6): 623-32[DOI][PubMed]
25.
Girish C, Raj V, Arya J, Balakrishnan S. Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice. Eur J Pharmacol. 2012; 682(1-3): 118-25[DOI][PubMed]